标题
Prognostic factors related with survival in patients with pancreatic adenocarcinoma
作者
关键词
-
出版物
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 20, Issue 31, Pages 10802
出版商
Baishideng Publishing Group Inc.
发表日期
2014-08-27
DOI
10.3748/wjg.v20.i31.10802
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immunohistochemically Detected Expression of 3 Major Genes (CDKN2A/p16, TP53, and SMAD4/DPC4) Strongly Predicts Survival in Patients With Resectable Pancreatic Cancer
- (2013) Minoru Oshima et al. ANNALS OF SURGERY
- Prognostic significance of epidermal growth factor receptor overexpression in pancreas cancer and nodal metastasis
- (2013) Marcos Vinicius Perini et al. ANZ JOURNAL OF SURGERY
- Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer
- (2013) M Stotz et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The relationship between multiple clinicopathological features and nerve invasion in pancreatic cancer
- (2013) Pao-Hsun Wang et al. Hepatobiliary & Pancreatic Diseases International
- Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy
- (2013) Michael Haas et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Prediagnostic Body Mass Index and Pancreatic Cancer Survival
- (2013) Chen Yuan et al. JOURNAL OF CLINICAL ONCOLOGY
- A requirement for Nedd9 in luminal progenitor cells prior to mammary tumorigenesis in MMTV-HER2/ErbB2 mice
- (2013) J L Little et al. ONCOGENE
- B7H4, HSP27 and DJ-1 molecular markers as prognostic factors in pancreatic cancer
- (2013) A. Tsiaousidou et al. PANCREATOLOGY
- Serum CA 19-9 and CEA Levels as a Prognostic Factor in Pancreatic Adenocarcinoma
- (2013) Kyong Joo Lee et al. YONSEI MEDICAL JOURNAL
- Jaundice: an important, poorly recognized risk factor for diminished survival in patients with adenocarcinoma of the head of the pancreas
- (2013) Steven M. Strasberg et al. HPB
- Lymph node ratio and preoperative CA 19-9 levels predict overall survival and recurrence-free survival in patients with resected pancreatic adenocarcinoma
- (2013) Sabrina C Wentz World Journal of Gastrointestinal Oncology
- The prognostic and predictive value of serum CA19.9 in pancreatic cancer
- (2012) J. L. Humphris et al. ANNALS OF ONCOLOGY
- Obesity and survival in population-based patients with pancreatic cancer in the San Francisco Bay Area
- (2012) Zhihong Gong et al. CANCER CAUSES & CONTROL
- Impact of the Integrin Signaling Adaptor Protein NEDD9 on Prognosis and Metastatic Behavior of Human Lung Cancer
- (2012) S. Kondo et al. CLINICAL CANCER RESEARCH
- Translational Therapeutic Opportunities in Ductal Adenocarcinoma of the Pancreas
- (2012) M. Hidalgo et al. CLINICAL CANCER RESEARCH
- Association of body mass index and risk of death from pancreas cancer in Asians
- (2012) Yingsong Lin et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Performance status of patients is the major prognostic factor at all stages of pancreatic cancer
- (2012) Faruk Tas et al. International Journal of Clinical Oncology
- N0/N1, PNL, or LNR? The Effect of Lymph Node Number on Accurate Survival Prediction in Pancreatic Ductal Adenocarcinoma
- (2012) Nakul P. Valsangkar et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Overexpression of FOXM1 Is Associated With Poor Prognosis and Clinicopathologic Stage of Pancreatic Ductal Adenocarcinoma
- (2012) Jin-Tang Xia et al. PANCREAS
- SMAD4 Genetic Alterations Predict a Worse Prognosis in Patients With Pancreatic Ductal Adenocarcinoma
- (2012) Puneet Singh et al. PANCREAS
- Expression of NEDD9 in pancreatic ductal adenocarcinoma and its clinical significance
- (2012) Yu-Zheng Xue et al. TUMOR BIOLOGY
- Prognostic factors in patients with pancreatic cancer
- (2011) DE-XIANG ZHANG et al. Experimental and Therapeutic Medicine
- Adjuvant Therapy in Pancreatic Cancer
- (2010) Amy Thomas et al. DIGESTIVE DISEASES
- Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
- (2010) John P. Neoptolemos et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview
- (2010) S. Bünger et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Impact of Operative Blood Loss on Survival in Invasive Ductal Adenocarcinoma of the Pancreas
- (2010) Shunji Nagai et al. PANCREAS
- Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP)
- (2010) Krishna V. Menon et al. HPB
- Temporal Association of Changes in Fasting Blood Glucose and Body Mass Index With Diagnosis of Pancreatic Cancer
- (2009) Rahul Pannala et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report
- (2009) M. J. Duffy et al. ANNALS OF ONCOLOGY
- SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer
- (2009) A. Blackford et al. CLINICAL CANCER RESEARCH
- Survival and Prognostic Factors of Unresectable Pancreatic Cancer
- (2009) Joo Kyung Park et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Can preoperative CA19-9 and CEA levels predict the resectability of patients with pancreatic adenocarcinoma?
- (2009) Young Choon Kim et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The Lymph Node Ratio is the Strongest Prognostic Factor after Resection of Pancreatic Cancer
- (2009) Hartwig Riediger et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Prognostic implications of tumor invasion or adhesion to peripancreatic vessels in resected pancreatic cancer
- (2009) Ugo Boggi et al. SURGERY
- Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma
- (2008) Richard A. Smith et al. AMERICAN JOURNAL OF SURGERY
- Preoperative Resolution of Jaundice Following Biliary Stenting Predicts More Favourable Early Survival in Resected Pancreatic Ductal Adenocarcinoma
- (2008) Richard A. Smith et al. ANNALS OF SURGICAL ONCOLOGY
- Influence of Resection Margins and Treatment on Survival in Patients With Pancreatic Cancer
- (2008) Giovanni Butturini ARCHIVES OF SURGERY
- Modelling prognostic factors in advanced pancreatic cancer
- (2008) D D Stocken et al. BRITISH JOURNAL OF CANCER
- Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer
- (2008) James J. Farrell et al. GASTROENTEROLOGY
- CA 19-9 as a Predictor for Response and Survival in Advanced Pancreatic Cancer Patients Treated With Chemoradiotherapy
- (2008) Woong Sub Koom et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Fluorouracil vs Gemcitabine Chemotherapy Before and After Fluorouracil-Based Chemoradiation Following Resection of Pancreatic Adenocarcinoma
- (2008) William F. Regine et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Preoperative Platelet Count and Survival Prognosis in Resected Pancreatic Ductal Adenocarcinoma
- (2008) Ismael Domínguez et al. WORLD JOURNAL OF SURGERY
- Clinical and pathologic prognostic factors for curative resection for pancreatic cancer
- (2008) M.V. Perini et al. HPB
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now